trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['solid tumor', 'pantumor', 't-dxd', 'daiichi', 'astrazeneca']
#asco23 brings you late breaking abstract on efficacy &amp; safety from destiny-pantumor02 of t-dxd in patients with her2-expressing solid tumors with dr. funda meric-bernstam. hall d2 at 8am for more on #solidtumors 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how HCPs stay up-to-date.